Clinical Evaluation of Vatha Karappan (Ecezma)

Phase 2

Completed

• Conditions: Patients with symptoms ofSkin rashes or bumpy rashes or blisters,Papules, vesicles, pustules

• Registration Number: CTRI/2016/06/006983
• Lead Sponsor: National institute of Siddha

Brief Summary

To evaluate the therapeutic efficacy of siddha polyherbal formulation Charanai kudineer (internal medicine) and Boothakarappan pattai ennai (external medicine)in the treatment of Ecezma , I BELIVE IT WORK WELL

Detailed Description

Not available

Study Timeline

• Study Start: 2015-10-31
• Last Update Posted: 2017-04-21

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Inclusion criteria 1.
• Age 7 to 12 years 2.Skin rashes or bumpy rashes or blisters, Papules, vesicles, pustules, Ulcer formation with oozing, Swelling, Pain, Fever 3.
• Patients willing to give specimen of blood for investigation when required.
• Patients willing to be admitted in the hospital or willing to attend OPD once in 7 days for 14 days.

Exclusion Criteria

Scabies Photo dermatitis Patient with any other serious illness which needs discontinuity of trial drug Seborrhoeic dermatitis Nummular dermatitis Fungal or parasitic skin infections.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Moderate-reduced some clinical symptoms	With in 14 days
Poor-No improvement or change in clinical symptoms	With in 14 days
Good-reduced all clinical symptoms	With in 14 days

Secondary Outcome Measures

Name	Time	Method
It is mainly assessed by therapeutic efficacy of the trial drugs	1-3 months

Trial Locations

Locations (1)

National Institute of Siddha; 🇮🇳 Chennai, TAMIL NADU, India

National Institute of Siddha

🇮🇳Chennai, TAMIL NADU, India

DrEIndumathi

Principal investigator

9994594075

indumathi13887@gmail.com